SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14D-9

(Rule 14d-101)

Solicitation/Recommendation Statement

Under Section 14(d)(4) of the Securities Exchange Act of 1934

 

 

ZymoGenetics, Inc.

(Name of Subject Company)

ZymoGenetics, Inc.

(Name of Person Filing Statement)

Common Stock, no par value

(Title of Class of Securities)

98985T109

(CUSIP Number of Class of Securities)

 

 

James A. Johnson

Executive Vice President, Chief Financial Officer, Secretary and Treasurer

1201 Eastlake Avenue East,

Seattle, Washington 98102

(206) 442-6600

(Name, address and telephone number of person authorized to receive

notices and communications on behalf of the persons filing statement)

With copies to:

Peter F. Kerman

Joshua M. Dubofsky

Latham & Watkins LLP

140 Scott Drive

Menlo Park, CA 94025

(650) 328-4600

 

x Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

 

 

 

The information set forth under Items 1.01, 5.02 and 9.01 of the Current Report on Form 8-K filed by ZymoGenetics, Inc. on September 8, 2010 (including all exhibits attached thereto) are incorporated herein by reference.

Grafico Azioni Generation Z ETF (NASDAQ:ZGEN)
Storico
Da Ott 2024 a Nov 2024 Clicca qui per i Grafici di Generation Z ETF
Grafico Azioni Generation Z ETF (NASDAQ:ZGEN)
Storico
Da Nov 2023 a Nov 2024 Clicca qui per i Grafici di Generation Z ETF